Countering the Gastric ph Effect of a Standardized Meal in Healthy Volunteers Using Clinical Doses of Betaine Hydrochloride
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 9
- 试验地点
- 2
- 主要终点
- Change in Gastric pH After Administration of Standardized Meal
研究概览
简要总结
Food will decrease stomach acidity due to its buffering effect.This has implications when providing drugs that are dosed with food but require higher levels of stomach acid, such as some medications commonly used for HIV patients. This study will attempt to determine the dose of betaine hydrochloride (over the counter acid supplement) at which the effect of food on stomach acid could be countered. Additionally, this study will evaluate the ability of a natural supplement (betaine hydrochloride) to affect the gastric pH following a standardized meal in healthy volunteers. The investigators predict that 4500mg of betaine hydrochloride will have the greatest effect on gastric pH.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or female 18-64 years of age;
- •Healthy adult with no active medical problems or significant chronic diseases as determined by the study doctor based on history, physical exam;
- •BMI between 18.5 - 32 kg/m2;
- •Taking no medications 2 weeks before and during the study enrollment, including drugs of abuse, prescription or OTC medications (except acetaminophen);
- •Be able to provide written informed consent and comply with requirements of the study;
- •Avoid eating grapefruit and drinking grapefruit juice from 7 days before the first study day until completion of the entire study;
- •Abstinence from alcoholic beverages, caffeinated beverages and orange juice from 3pm the night before a study day until completion of that study day;
- •Fast from food and beverages at least 8 hours prior to the study day;
- •Be able to read, speak and understand English
排除标准
- •Subjects with a history of gastrointestinal disease including gastroesophageal reflux disease, gastritis, peptic ulcer disease or dyspepsia.
- •Subjects with a fasting gastric pH of > 4 (i.e. hypochlorhydria)
- •Subjects with history of dysphagia, achalasia, or difficulty swallowing capsules, tablets or pills.
- •Subjects on prescription or chronic over-the counter medications (including hormonal contraceptives);
- •Subjects with liver failure or LFTs >2x upper limit of normal;
- •Subjects with clinically significant elevations in SCr, BUN or other screening laboratory tests as determined by study physician;
- •Subjects with Hct < 30 mg/dL, WBC < 2000/μL, ANC < 1000/μL, or platelet count < 150,000/μL;
- •Subjects with a history or presence of an abnormal ECG, including demonstration of a baseline corrected Fridericia's QT interval (QTcF) >450ms, which in the opinion of the study physician, is clinically significant;
- •Subjects who smoke tobacco;
- •Subjects with ongoing alcohol or illegal drug use;
- •Subjects who are pregnant, lactating or attempting to conceive;
- •Subjects unable to follow protocol instructions or protocol criteria.
- •Anyone who in the opinion of the study investigators is unable to participate in the study.
结局指标
主要结局
Change in Gastric pH After Administration of Standardized Meal
时间窗: 15 minutes
After Heidelberg capsule is placed and baseline gastric levels have been recorded using the Heidelberg Capsule (HC), which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis, a standardized meal is given. Gastric pH is measured for 15 minutes after the administration of the meal.
Change in Gastric pH After Administration of Standardized Meal and Betaine hydrochloride
时间窗: 3 hours
After 15 minutes of gastric pH monitoring following the standardized meal, betaine hydrochloride will be administered and its effect on the ability to mitigate that rise in gastric pH will be determined using the Heidelberg capsule over the span of approximately 3 hours. This will be done three separate times with 3 doses (1500mg, 3000mg, and 4500mg) dosed orally with 90ml of water.
次要结局
未报告次要终点